The aim of this study was to determine if a baseline high-sensitivity troponin T (hsTnT) value ≤99th percentile upper reference limit (0.014 μg/l ["low hsTnT"]) identifies patients at low risk for adverse outcomes.

Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial / Pang, Peter S; Teerlink, John R; Voors, Adriaan A; Ponikowski, Piotr; Greenberg, Barry H; Filippatos, Gerasimos; Felker, G Michael; Davison, Beth A; Cotter, Gad; Kriger, Joshua; Prescott, Margaret F; Hua, Tsushung A; Severin, Thomas; Metra, Marco. - In: JACC. HEART FAILURE. - ISSN 2213-1787. - 4:7(2016), pp. 591-599. [10.1016/j.jchf.2016.02.009]

Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial

Metra, Marco
2016-01-01

Abstract

The aim of this study was to determine if a baseline high-sensitivity troponin T (hsTnT) value ≤99th percentile upper reference limit (0.014 μg/l ["low hsTnT"]) identifies patients at low risk for adverse outcomes.
2016
acute heart failure
emergency department
risk stratification
serelaxin
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/193509
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 48
social impact